{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:40:23Z","timestamp":1786981223449,"version":"build-2736575974"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10787-022-01099-4","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:24:51Z","timestamp":1669281891000},"page":"221-230","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Benzodiazepines in Alzheimer\u2019s disease: beneficial or detrimental effects"],"prefix":"10.1007","volume":"31","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9555-7300","authenticated-orcid":false,"given":"Hebatallah M.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"1099_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5114\/aoms.2011.20612","volume":"7","author":"PS Aisen","year":"2011","unstructured":"Aisen PS, Gauthier S, Ferris SH, Saumier D, Haine D, Garceau D, Duong A, Suhy J, Oh J, Lau WC (2011) Tramiprosate in mild-to-moderate Alzheimer\u2019s disease\u2013a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase study). Arch Med Sci 7:102\u2013111","journal-title":"Arch Med Sci"},{"key":"1099_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.medcle.2020.02.011","volume":"156","author":"P Aldaz","year":"2021","unstructured":"Aldaz P, Garj\u00f3n J, Beitia G, Beltr\u00e1n I, Librero J, Ib\u00e1\u00f1ez B, Arroyo P, Ariz MJ (2021) Association between benzodiazepine use and development of dementia. Medicina Cl\u00ednica (english Edition) 156:107\u2013111","journal-title":"Medicina Cl\u00ednica (english Edition)"},{"key":"1099_CR3","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.3390\/jcm10081754","volume":"10","author":"S Almohaish","year":"2021","unstructured":"Almohaish S, Sandler M, Brophy GM (2021) Time is brain: acute control of repetitive seizures and status epilepticus using alternative routes of administration of benzodiazepines. J Clin Med 10:1754","journal-title":"J Clin Med"},{"key":"1099_CR4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.3390\/brainsci12101290","volume":"12","author":"N Alsubaie","year":"2022","unstructured":"Alsubaie N, Al-kuraishy HM, Al-Gareeb AI, Alharbi B, De Waard M, Sabatier J-M, Saad HM, Batiha GE-S (2022) Statins use in Alzheimer disease: bane or boon from frantic search and narrative review. Brain Sci 12:1290","journal-title":"Brain Sci"},{"issue":"11","key":"1099_CR5","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1111\/cns.13914","volume":"28","author":"J Aran\u0111elovi\u0107","year":"2022","unstructured":"Aran\u0111elovi\u0107 J, Santra\u010d A, Batini\u0107 B, Todorovi\u0107 L, Stevanovi\u0107 V, Tiruveedhula VVNPB, Sharmin D, Rashid F, Stanojevi\u0107 B, Cook JM (2022) Effects of \u03b15 GABAA receptor modulation on social interaction, memory, and neuroinflammation in a mouse model of Alzheimer\u2019s disease. CNS Neurosci Ther 28(11):1767\u20131778","journal-title":"CNS Neurosci Ther"},{"key":"1099_CR6","first-page":"1","volume":"1","author":"S Arshad","year":"2018","unstructured":"Arshad S, Butt J, Iqbal J, ul Hassan SS, (2018) Abuses and misuses of benzodiazepines and antidepressents; a review. Mod Appl Pharm Pharmacol 1:1\u20136","journal-title":"Mod Appl Pharm Pharmacol"},{"issue":"201\u2013211","key":"1099_CR7","first-page":"e202","volume":"21","author":"Y-H Baek","year":"2020","unstructured":"Baek Y-H, Lee H, Kim WJ, Chung J-E, Pratt N, Ellett LK, Shin J-Y (2020) Uncertain association between benzodiazepine use and the risk of dementia: a cohort study. J Am Med Dir Assoc 21(201\u2013211):e202","journal-title":"J Am Med Dir Assoc"},{"key":"1099_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","volume":"19","author":"MJ Barker","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF (2004) Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol 19:437\u2013454","journal-title":"Arch Clin Neuropsychol"},{"key":"1099_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-92919-4_11","volume-title":"Benzodiazepines and Z-Drugs in Pregnancy","author":"C Bellantuono","year":"2019","unstructured":"Bellantuono C, Martellini M, Orsolini L (2019) Benzodiazepines and Z-Drugs in Pregnancy. Perinatal Psychopharmacology, Springer, Cham"},{"key":"1099_CR10","volume-title":"StatPearls [Internet]","author":"CG Bounds","year":"2020","unstructured":"Bounds CG, Nelson VL (2020) Benzodiazepines. StatPearls [Internet]. StatPearls Publishing, United States"},{"key":"1099_CR11","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.neuropharm.2017.10.022","volume":"128","author":"ML Brady","year":"2018","unstructured":"Brady ML, Pilli J, Lorenz-Guertin JM, Das S, Moon CE, Graff N, Jacob TC (2018) Depolarizing, inhibitory GABA type a receptor activity regulates GABAergic synapse plasticity via ERK and BDNF signaling. Neuropharmacology 128:324\u2013339","journal-title":"Neuropharmacology"},{"key":"1099_CR12","first-page":"1","volume":"2020","author":"F Brigo","year":"2020","unstructured":"Brigo F, Lattanzi S (2020) Anticonvulsant agents: benzodiazepines (clobazam, clonazepam, diazepam, lorazepam, midazolam). NeuroPsychopharmacotherapy 2020:1\u20138","journal-title":"NeuroPsychopharmacotherapy"},{"key":"1099_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.phrs.2018.04.017","volume":"132","author":"A Caruso","year":"2018","unstructured":"Caruso A, Nicoletti F, Mango D, Saidi A, Orlando R, Scaccianoce S (2018) Stress as risk factor for Alzheimer\u2019s disease. Pharmacol Res 132:130\u2013134","journal-title":"Pharmacol Res"},{"key":"1099_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-021-02805-0","volume":"17","author":"M Charalambous","year":"2021","unstructured":"Charalambous M, Volk HA, Van Ham L, Bhatti SF (2021) First-line management of canine status epilepticus at home and in hospital-opportunities and limitations of the various administration routes of benzodiazepines. BMC Vet Res 17:1\u201319","journal-title":"BMC Vet Res"},{"key":"1099_CR15","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2019.00659","volume":"13","author":"X-Q Chen","year":"2019","unstructured":"Chen X-Q, Mobley WC (2019) Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species. Front Neurosci 13:659","journal-title":"Front Neurosci"},{"key":"1099_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","volume":"109","author":"Y Chen","year":"2021","unstructured":"Chen Y, Strickland MR, Soranno A, Holtzman DM (2021) Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis. Neuron 109:205\u2013221","journal-title":"Neuron"},{"key":"1099_CR17","doi-asserted-by":"publisher","first-page":"41115","DOI":"10.1074\/jbc.M111.248534","volume":"286","author":"S Cho","year":"2011","unstructured":"Cho S, Park JS, Kang Y-K (2011) Dual functions of histone-lysine N-methyltransferase Setdb1 protein at promyelocytic leukemia-nuclear body (PML-NB): maintaining PML-NB structure and regulating the expression of its associated genes. J Biol Chem 286:41115\u201341124","journal-title":"J Biol Chem"},{"key":"1099_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.bpa.2018.06.007","volume":"32","author":"EM Cornett","year":"2018","unstructured":"Cornett EM, Novitch MB, Brunk AJ, Davidson KS, Menard BL, Urman RD, Kaye AD (2018) New benzodiazepines for sedation. Best Pract Res Clin Anaesthesiol 32:149\u2013164","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"1099_CR19","first-page":"144","volume":"21","author":"E Dailly","year":"2008","unstructured":"Dailly E, Bourin M (2008) The use of benzodiazepines in the aged patient: clinical and pharmacological considerations. Pak J Pharm Sci 21:144\u2013150","journal-title":"Pak J Pharm Sci"},{"key":"1099_CR20","doi-asserted-by":"publisher","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"SB De Gage","year":"2014","unstructured":"De Gage SB, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, B\u00e9gaud B (2014) Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ 349:g5205","journal-title":"BMJ"},{"key":"1099_CR21","doi-asserted-by":"publisher","first-page":"pyv055","DOI":"10.1093\/ijnp\/pyv055","volume":"18","author":"M Defrancesco","year":"2015","unstructured":"Defrancesco M, Marksteiner J, Fleischhacker WW, Blasko I (2015) Use of benzodiazepines in Alzheimer\u2019s disease: a systematic review of literature. Int J Neuropsychopharmacol 18:pyv055","journal-title":"Int J Neuropsychopharmacol"},{"key":"1099_CR22","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/md18110566","volume":"18","author":"L Delgado-Roche","year":"2020","unstructured":"Delgado-Roche L, Santes-Palacios R, Herrera JA, Hern\u00e1ndez SL, Riera M, Fern\u00e1ndez MD, Mesta F, Garrido G, Rodeiro I, Espinosa-Aguirre JJ (2020) Interaction of Thalassia testudinum metabolites with cytochrome P450 enzymes and its effects on benzo (a) pyrene-induced mutagenicity. Mar Drugs 18:566","journal-title":"Mar Drugs"},{"key":"1099_CR23","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.envpol.2018.06.042","volume":"241","author":"C Della Torre","year":"2018","unstructured":"Della Torre C, Maggioni D, Ghilardi A, Parolini M, Santo N, Landi C, Madaschi L, Magni S, Tasselli S, Ascagni M (2018) The interactions of fullerene C60 and Benzo (\u03b1) pyrene influence their bioavailability and toxicity to zebrafish embryos. Environ Pollut 241:999\u20131008","journal-title":"Environ Pollut"},{"key":"1099_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2019.08.008","volume":"84","author":"T Desmidt","year":"2019","unstructured":"Desmidt T, Delrieu J, Lebouvier T, Robert G, David R, Balageas A-C, Surget A, Belzung C, Arlicot N, Ribeiro M-J (2019) Benzodiazepine use and brain amyloid load in nondemented older individuals: a florbetapir PET study in the multidomain Alzheimer preventive trial cohort. Neurobiol Aging 84:61\u201369","journal-title":"Neurobiol Aging"},{"key":"1099_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.trsl.2016.12.005","volume":"183","author":"T Diehl","year":"2017","unstructured":"Diehl T, Mullins R, Kapogiannis D (2017) Insulin resistance in Alzheimer\u2019s disease. Transl Res 183:26\u201340","journal-title":"Transl Res"},{"key":"1099_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF02246647","volume":"123","author":"T Duka","year":"1996","unstructured":"Duka T, Ott H, Rohloff A, Voet B (1996) The effects of a benzodiazepine receptor antagonist \u03b2-carboline ZK-93426 on scopolamine-induced impairment on attention, memory and psychomotor skills. Psychopharmacology 123:361\u2013373","journal-title":"Psychopharmacology"},{"key":"1099_CR27","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jamda.2019.08.006","volume":"21","author":"AH Dyer","year":"2020","unstructured":"Dyer AH, Murphy C, Lawlor B, Kennelly SP, Segurado R, Kennelly S, Rikkert MGO, Howard R, Pasquier F, B\u00f6rjesson-Hanson A (2020) Cognitive outcomes of long-term benzodiazepine and related drug (BDZR) use in people living with mild to moderate Alzheimer\u2019s disease: results from NILVAD. J Am Med Dir Assoc 21:194\u2013200","journal-title":"J Am Med Dir Assoc"},{"key":"1099_CR28","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J, Sagrera CE, Delacroix BM, Abubakar T, Cornett EM, Kaye AM, Kaye AD (2021) Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int 13:594\u2013607","journal-title":"Neurol Int"},{"key":"1099_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/neurolint14030053","volume":"14","author":"AN Edinoff","year":"2022","unstructured":"Edinoff AN, Nix CA, Odisho AS, Babin CP, Derouen AG, Lutfallah SC, Cornett EM, Murnane KS, Kaye AM, Kaye AD (2022) Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects. Neurol Int 14:648\u2013663","journal-title":"Neurol Int"},{"key":"1099_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.neuropharm.2017.08.012","volume":"125","author":"L-A Etherington","year":"2017","unstructured":"Etherington L-A, Mihalik B, P\u00e1lv\u00f6lgyi A, Ling I, Pallagi K, Kert\u00e9sz S, Varga P, Gunn BG, Brown AR, Livesey MR (2017) Selective inhibition of extra-synaptic \u03b15-GABAA receptors by S44819, a new therapeutic agent. Neuropharmacology 125:353\u2013364","journal-title":"Neuropharmacology"},{"key":"1099_CR31","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fnagi.2019.00344","volume":"11","author":"M Ettcheto","year":"2020","unstructured":"Ettcheto M, Olloquequi J, S\u00e1nchez-L\u00f3pez E, Busquets O, Cano A, Manzine PR, Beas-Zarate C, Castro-Torres RD, Garc\u00eda ML, Bull\u00f3 M (2020) Benzodiazepines and related drugs as a risk factor in Alzheimer\u2019s disease dementia. Front Aging Neurosci 11:344","journal-title":"Front Aging Neurosci"},{"key":"1099_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00002093-199803000-00002","volume":"12","author":"J Fastbom","year":"1998","unstructured":"Fastbom J, Forsell Y, Winblad B (1998) Benzodiazepines may have protective effects against Alzheimer disease. Alzheimer Dis Assoc Disord 12:14\u201317","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1099_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2019.02.016","volume":"364","author":"AT Frias","year":"2019","unstructured":"Frias AT, Fernandes GG, Zangrossi H Jr (2019) GABAA\/benzodiazepine receptors in the dorsal periaqueductal gray mediate the panicolytic but not the anxiolytic effect of alprazolam in rats. Behav Brain Res 364:99\u2013105","journal-title":"Behav Brain Res"},{"key":"1099_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019264","volume":"6","author":"D Frost","year":"2011","unstructured":"Frost D, Meechoovet B, Wang T, Gately S, Giorgetti M, Shcherbakova I, Dunckley T (2011) \u03b2-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer\u2019s disease-related sites. PLoS ONE 6:e19264","journal-title":"PLoS ONE"},{"key":"1099_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/jech-2011-200314","volume":"66","author":"J Gallacher","year":"2012","unstructured":"Gallacher J, Elwood P, Pickering J, Bayer A, Fish M, Ben-Shlomo Y (2012) Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). J Epidemiol Comm Health 66:869\u2013873","journal-title":"J Epidemiol Comm Health"},{"key":"1099_CR36","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/s41386-021-01246-5","volume":"47","author":"Q Gallet","year":"2022","unstructured":"Gallet Q, Bouteloup V, Locatelli M, Habert M-O, Chupin M, Delrieu J, Lebouvier T, Robert G, David R, Bulteau S (2022) Benzodiazepine use and neuroimaging markers of Alzheimer\u2019s disease in nondemented older individuals: an MRI and 18F Florbetapir PET study in the MEMENTO cohort. Neuropsychopharmacology 47:1114\u20131120","journal-title":"Neuropsychopharmacology"},{"key":"1099_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fmars.2018.00099","volume":"5","author":"A Gomiero","year":"2018","unstructured":"Gomiero A, Strafella P, Pellini G, Salvalaggio V, Fabi G (2018) Comparative effects of ingested PVC micro particles with and without adsorbed benzo (a) pyrene vs spiked sediments on the cellular and sub cellular processes of the benthic organism Hediste diversicolor. Frontiers in Mar Sci 5:99","journal-title":"Frontiers in Mar Sci"},{"key":"1099_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/08971900221097182","author":"J Gonzalez","year":"2022","unstructured":"Gonzalez J, Upadhyaya VD, Manna ZT, Sharma AR, Christopher J, Douedi S, Sen S (2022) Paradoxical excitation following intravenous lorazepam administration for alcohol withdrawal\u2013a case presentation and literature review. J Pharm Pract. https:\/\/doi.org\/10.1177\/08971900221097182","journal-title":"J Pharm Pract"},{"key":"1099_CR39","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1021\/jm801599a","volume":"52","author":"G Guerrini","year":"2009","unstructured":"Guerrini G, Ciciani G, Cambi G, Bruni F, Selleri S, Guarino C, Melani F, Montali M, Martini C, Ghelardini C (2009) Synthesis, in vivo evaluation, and molecular modeling studies of new pyrazolo [5, 1-c][1, 2, 4] benzotriazine 5-oxide derivatives. Identification of a bifunctional hydrogen bond area related to the inverse agonism. J Med Chem 52:4668\u20134682","journal-title":"J Med Chem"},{"key":"1099_CR40","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1021\/jm701433b","volume":"51","author":"D Harris","year":"2008","unstructured":"Harris D, Clayton T, Cook J, Sahbaie P, Halliwell RF, Furtm\u00fcller R, Huck S, Sieghart W, DeLorey TM (2008) Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the \u03b15 subunit. J Med Chem 51:3788\u20133803","journal-title":"J Med Chem"},{"key":"1099_CR41","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41583-018-0113-1","volume":"20","author":"CM Henstridge","year":"2019","unstructured":"Henstridge CM, Hyman BT, Spires-Jones TL (2019) Beyond the neuron\u2013cellular interactions early in Alzheimer disease pathogenesis. Nat Rev Neurosci 20:94\u2013108","journal-title":"Nat Rev Neurosci"},{"key":"1099_CR42","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000454881","volume":"47","author":"MM Islam","year":"2016","unstructured":"Islam MM, Iqbal U, Walther B, Atique S, Dubey NK, Nguyen P-A, Poly TN, Masud JHB, Li Y-CJ, Shabbir S-A (2016) Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology 47:181\u2013191","journal-title":"Neuroepidemiology"},{"key":"1099_CR43","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s41999-020-00376-1","volume":"11","author":"MA Izza","year":"2020","unstructured":"Izza MA, Lunt E, Gordon AL, Gladman JR, Armstrong S, Logan P (2020) Polypharmacy, benzodiazepines, and antidepressants, but not antipsychotics, are associated with increased falls risk in UK care home residents: a prospective multi-centre study. Eur Geriatr Med 11:1043\u20131050","journal-title":"Eur Geriatr Med"},{"key":"1099_CR44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40268-019-00282-3","volume":"19","author":"B Ji","year":"2019","unstructured":"Ji B, Liu S, Xue Y, He X, Man VH, Xie X-Q, Wang J (2019) Prediction of drug\u2013drug interactions between opioids and overdosed benzodiazepines using physiologically based pharmacokinetic (PBPK) modeling and simulation. Drugs R&d 19:297\u2013305","journal-title":"Drugs R&d"},{"key":"1099_CR45","volume":"8","author":"G Joyce","year":"2022","unstructured":"Joyce G, Ferido P, Thunell J, Tysinger B, Zissimopoulos J (2022) Benzodiazepine use and the risk of dementia. Alzheimer\u2019s Dementia 8:e12309","journal-title":"Alzheimer\u2019s Dementia"},{"key":"1099_CR46","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/01616412.2021.1949689","volume":"43","author":"E Keskin","year":"2021","unstructured":"Keskin E, Can EY, Ayd\u0131n HA, I\u015f\u0131k E, \u00d6zgen U, \u015eim\u015fek K, Cengil O, Ba\u015far C, Kalayc\u0131 M (2021) The preventative effect of of Ro5-4864 (peripheral benzodiazepine receptor agonist) on spinal epidural fibrosis after laminectomy in a rat model. Neurol Res 43:1107\u20131115","journal-title":"Neurol Res"},{"key":"1099_CR47","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1471-4159.2010.06961.x","volume":"115","author":"G Kleinberger","year":"2010","unstructured":"Kleinberger G, Wils H, Ponsaerts P, Joris G, Timmermans JP, Van Broeckhoven C, Kumar-Singh S (2010) Increased caspase activation and decreased TDP-43 solubility in progranulin knockout cortical cultures. J Neurochem 115:735\u2013747","journal-title":"J Neurochem"},{"key":"1099_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-020-00234-1","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT, Nixon RA, Jones DT (2021) Tendinopathy. Nat Rev Dis Primers 7:1\u201321","journal-title":"Nat Rev Dis Primers"},{"key":"1099_CR49","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.55729","author":"PF Kramer","year":"2020","unstructured":"Kramer PF, Twedell EL, Shin JH, Zhang R, Khaliq ZM (2020) Axonal mechanisms mediating \u03b3-aminobutyric acid receptor type a (GABA-A) inhibition of striatal dopamine release. Elife. https:\/\/doi.org\/10.7554\/eLife.55729","journal-title":"Elife"},{"key":"1099_CR50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3233\/JAD-180745","volume":"66","author":"Z Kurlawala","year":"2018","unstructured":"Kurlawala Z, Roberts JA, McMillan JD, Friedland RP (2018) Diazepam toxicity presenting as a dementia disorder. J Alzheimers Dis 66:935\u2013938","journal-title":"J Alzheimers Dis"},{"key":"1099_CR51","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/jnc.14325","volume":"145","author":"A Kwakowsky","year":"2018","unstructured":"Kwakowsky A, Calvo-Flores Guzm\u00e1n B, Pandya M, Turner C, Waldvogel HJ, Faull RL (2018a) GABAA receptor subunit expression changes in the human Alzheimer\u2019s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus. J Neurochem 145:374\u2013392","journal-title":"J Neurochem"},{"key":"1099_CR52","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.4103\/1673-5374.235240","volume":"13","author":"A Kwakowsky","year":"2018","unstructured":"Kwakowsky A, Guzm\u00e1n BC-F, Govindpani K, Waldvogel HJ, Faull RL (2018b) Gamma-aminobutyric acid a receptors in Alzheimer\u2019s disease: highly localized remodeling of a complex and diverse signaling pathway. Neural Regen Res 13:1362","journal-title":"Neural Regen Res"},{"key":"1099_CR53","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.4103\/1673-5374.300987","volume":"16","author":"A Kwakowsky","year":"2021","unstructured":"Kwakowsky A, Waldvogel HJ, Faull RL (2021) Therapeutic potential of alpha 5 subunit containing GABAA receptors in Alzheimer\u2019s disease. Neural Regen Res 16:1550","journal-title":"Neural Regen Res"},{"key":"1099_CR54","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/AOG.0000000000003267","volume":"133","author":"G Lamvu","year":"2019","unstructured":"Lamvu G, Soliman AM, Manthena SR, Gordon K, Knight J, Taylor HS (2019) Patterns of prescription opioid use in women with endometriosis: evaluating prolonged use, daily dose, and concomitant use with benzodiazepines. Obstet Gynecol 133:1120","journal-title":"Obstet Gynecol"},{"key":"1099_CR55","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.neures.2005.04.008","volume":"52","author":"BY Lee","year":"2005","unstructured":"Lee BY, Ban JY, Seong YH (2005) Chronic stimulation of GABAA receptor with muscimol reduces amyloid \u03b2 protein (25\u201335)-induced neurotoxicity in cultured rat cortical cells. Neurosci Res 52:347\u2013356","journal-title":"Neurosci Res"},{"key":"1099_CR56","volume-title":"Naturally occurring benzodiazepines, endozepines, and their receptors","author":"JA LeQuang","year":"2021","unstructured":"LeQuang JA (2021) The effects of benzodiazepines on memory. Naturally occurring benzodiazepines, endozepines, and their receptors. CRC Press, Boca Raton"},{"key":"1099_CR57","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","volume":"5","author":"G Li","year":"2009","unstructured":"Li G, Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Ring K, Halabisky B, Deng C, Mahley RW, Huang Y (2009) GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell 5:634\u2013645","journal-title":"Cell Stem Cell"},{"key":"1099_CR58","first-page":"Cd012670","volume":"2","author":"Y Li","year":"2020","unstructured":"Li Y, Ma J, Jin Y, Li N, Zheng R, Mu W, Wang J, Si JH, Chen J, Shang HC (2020) Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit. The Cochrane Database Sys Rev 2:Cd012670","journal-title":"The Cochrane Database Sys Rev"},{"key":"1099_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.13678","author":"YH Lin","year":"2022","unstructured":"Lin YH, Chen MH, Chang YC, Chen L, Hsiung CA, Wu SI (2022) Prevalence of exposure to benzodiazepines among pregnant women in Taiwan: a nationwide longitudinal study. J Sleep Res. https:\/\/doi.org\/10.1111\/jsr.13678","journal-title":"J Sleep Res"},{"key":"1099_CR60","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s11739-020-02339-7","volume":"15","author":"N Lombardi","year":"2020","unstructured":"Lombardi N, Bettiol A, Crescioli G, Ravaldi C, Bonaiuti R, Venegoni M, Vighi GD, Mugelli A, Mannaioni G, Vannacci A (2020) Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments. Intern Emerg Med 15:1291\u20131302","journal-title":"Intern Emerg Med"},{"key":"1099_CR61","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/dta.2387","volume":"10","author":"KR Manchester","year":"2018","unstructured":"Manchester KR, Maskell PD, Waters L (2018) Experimental versus theoretical log D7. 4, pKa and plasma protein binding values for benzodiazepines appearing as new psychoactive substances. Drug Test Anal 10:1258\u20131269","journal-title":"Drug Test Anal"},{"key":"1099_CR62","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4103\/1673-5374.230276","volume":"13","author":"J Marsh","year":"2018","unstructured":"Marsh J, Alifragis P (2018) Synaptic dysfunction in Alzheimer\u2019s disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention. Neural Regen Res 13:616","journal-title":"Neural Regen Res"},{"key":"1099_CR63","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s12031-018-1246-4","volume":"67","author":"FH Mohamad","year":"2019","unstructured":"Mohamad FH, Has ATC (2019) The \u03b15-containing GABAA receptors\u2014a brief summary. J Mol Neurosci 67:343\u2013351","journal-title":"J Mol Neurosci"},{"key":"1099_CR64","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/10408444.2021.1907303","volume":"51","author":"RE Moustafa","year":"2021","unstructured":"Moustafa RE, Tarbah F, Saeed HS, Sharif SI (2021) Designer benzodiazepines versus prescription benzodiazepines: can structural relation predict the next step? Crit Rev Toxicol 51:249\u2013263","journal-title":"Crit Rev Toxicol"},{"key":"1099_CR65","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/1060028019882037","volume":"54","author":"M Nafti","year":"2020","unstructured":"Nafti M, Sirois C, Kr\u00f6ger E, Carmichael P-H, Laurin D (2020) Is benzodiazepine use associated with the risk of dementia and cognitive impairment\u2013not dementia in older persons? The Canadian study of health and aging. Ann Pharmacother 54:219\u2013225","journal-title":"Ann Pharmacother"},{"key":"1099_CR66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40780-018-0106-2","volume":"4","author":"Y Noguchi","year":"2018","unstructured":"Noguchi Y, Ueno A, Katsuno H, Otsubo M, Yoshida A, Kanematsu Y, Sugita I, Tachi T, Tsuchiya T, Teramachi H (2018) Analyses of non-benzodiazepine-induced adverse events and prognosis in elderly patients based on the Japanese adverse drug event report database. J Pharmaceut Health Care Sci 4:10","journal-title":"J Pharmaceut Health Care Sci"},{"key":"1099_CR67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.24875\/RMN.20000050","volume":"22","author":"LD Ochoa-de la Paz","year":"2021","unstructured":"Ochoa-de la Paz LD, Gulias-Ca\u00f1izo R, Ru\u00edz-Leyja ED, S\u00e1nchez-Castillo H, Parod\u00ed J (2021) The role of GABA neurotransmitter in the human central nervous system, physiology, and pathophysiology. Revista Mexicana De Neurociencia 22:67\u201376","journal-title":"Revista Mexicana De Neurociencia"},{"key":"1099_CR68","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1097\/JCP.0b013e318222810e","volume":"31","author":"N Pomara","year":"2011","unstructured":"Pomara N, Bruno D, Sidtis JJ, Lutz MW, Greenblatt DJ, Saunders AM, Roses AD (2011) Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE \u03b54-negative elderly. J Clin Psychopharmacol 31:544\u2013546","journal-title":"J Clin Psychopharmacol"},{"key":"1099_CR69","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1159\/000491657","volume":"47","author":"J Qu","year":"2018","unstructured":"Qu J, Yan H, Zheng Y, Xue F, Zheng Y, Fang H, Chang Y, Yang H, Zhang J (2018) The molecular mechanism of alpha-synuclein dependent regulation of protein phosphatase 2A activity. Cell Physiol Biochem 47:2613\u20132625","journal-title":"Cell Physiol Biochem"},{"key":"1099_CR70","doi-asserted-by":"publisher","first-page":"e07895","DOI":"10.1016\/j.heliyon.2021.e07895","volume":"7","author":"MH Ratner","year":"2021","unstructured":"Ratner MH, Downing SS, Guo O, Odamah KE, Stewart TM, Kumaresan V, Robitsek RJ, Xia W, Farb DH (2021) Prodromal dysfunction of \u03b15GABA-A receptor modulated hippocampal ripples occurs prior to neurodegeneration in the TgF344-AD rat model of Alzheimer\u2019s disease. Heliyon 7:e07895","journal-title":"Heliyon"},{"key":"1099_CR71","doi-asserted-by":"publisher","first-page":"P1622","DOI":"10.1016\/j.jalz.2018.07.211","volume":"14","author":"K Richardson","year":"2018","unstructured":"Richardson K, Loke Y, Savva GM, Howard RJ, Boyd P, Aldus C, Maidment ID, Steel N, Arthur A, Ballard C (2018) P4\u2013387: UNINTENDED EFFECTS OF Z-DRUGS (ZOLPIDEM, ZOPICLONE AND ZALEPLON) IN PEOPLE LIVING WITH DEMENTIA. Alzheimers Dement 14:P1622\u2013P1622","journal-title":"Alzheimers Dement"},{"key":"1099_CR72","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1471-4159.2007.04832.x","volume":"103","author":"RA Rissman","year":"2007","unstructured":"Rissman RA, De Blas AL, Armstrong DM (2007) GABAA receptors in aging and Alzheimer\u2019s disease. J Neurochem 103:1285\u20131292","journal-title":"J Neurochem"},{"key":"1099_CR73","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/gps.4821","volume":"33","author":"L Saarelainen","year":"2018","unstructured":"Saarelainen L, Tolppanen AM, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Taipale H (2018) Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: a matched cohort study. Int J Geriatr Psychiatry 33:583\u2013590","journal-title":"Int J Geriatr Psychiatry"},{"key":"1099_CR74","volume-title":"The chapters were prepared and presented at a small workshop in Boston in Jan 1989","author":"CE Salzman","year":"1991","unstructured":"Salzman CE, Lebowitz BD (1991) Anxiety in the elderly: Treatment and research. The chapters were prepared and presented at a small workshop in Boston in Jan 1989. Springer Publishing Company, Cham"},{"key":"1099_CR75","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2020.20040375","author":"C Salzman","year":"2020","unstructured":"Salzman C (2020) Do benzodiazepines cause Alzheimer\u2019s disease?\u202f: Am psychiatric assoc. Am J Psyc. https:\/\/doi.org\/10.1176\/appi.ajp.2020.20040375","journal-title":"Am J Psyc"},{"key":"1099_CR76","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.pnpbp.2010.01.004","volume":"34","author":"MM Savi\u0107","year":"2010","unstructured":"Savi\u0107 MM, Majumder S, Huang S, Edwankar RV, Furtm\u00fcller R, Joksimovi\u0107 S, Clayton T Sr, Ramerstorfer J, Milinkovi\u0107 MM, Roth BL (2010) Novel positive allosteric modulators of GABAA receptors: Do subtle differences in activity at \u03b11 plus \u03b15 versus \u03b12 plus \u03b13 subunits account for dissimilarities in behavioral effects in rats? Prog Neuropsychopharmacol Biol Psychiatry 34:376\u2013386","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1099_CR77","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/CCM.0000000000003231","volume":"46","author":"JN Schieveld","year":"2018","unstructured":"Schieveld JN, Strik JJ, Bruining H (2018) On benzodiazepines, paradoxical agitation, hyperactive delirium, and chloride homeostasis. Crit Care Med 46:1558\u20131559","journal-title":"Crit Care Med"},{"key":"1099_CR78","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1124\/pr.117.014449","volume":"70","author":"W Sieghart","year":"2018","unstructured":"Sieghart W, Savi\u0107 MM (2018) International Union of Basic and Clinical Pharmacology. CVI: GABA(A) Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans. Pharmacol Rev 70:836\u2013878","journal-title":"Pharmacol Rev"},{"key":"1099_CR79","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2165\/0002512-200926020-00003","volume":"26","author":"AJ Smith","year":"2009","unstructured":"Smith AJ, Tett SE (2009) How do different age groups use benzodiazepines and antidepressants? Analysis of an Australian administrative database, 2003\u20136. Drugs Aging 26:113\u2013122","journal-title":"Drugs Aging"},{"key":"1099_CR80","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnmol.2014.00016","volume":"7","author":"J-M Sontag","year":"2014","unstructured":"Sontag J-M, Sontag E (2014) Protein phosphatase 2A dysfunction in Alzheimer\u2019s disease. Front Mol Neurosci 7:16","journal-title":"Front Mol Neurosci"},{"key":"1099_CR81","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.4088\/JCP.08m04593","volume":"70","author":"CM Stonnington","year":"2009","unstructured":"Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ (2009) Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-\u03b54 carriers. J Clin Psychiatry 70:4746","journal-title":"J Clin Psychiatry"},{"key":"1099_CR82","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/S0002-9440(10)62486-8","volume":"166","author":"H Tanimukai","year":"2005","unstructured":"Tanimukai H, Grundke-Iqbal I, Iqbal K (2005) Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer\u2019s disease. Am J Pathol 166:1761\u20131771","journal-title":"Am J Pathol"},{"key":"1099_CR83","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.2147\/IJN.S200490","volume":"14","author":"S Tiwari","year":"2019","unstructured":"Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M (2019) Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Int J Nanomed 14:5541","journal-title":"Int J Nanomed"},{"key":"1099_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9171424","volume":"2019","author":"K Trevisan","year":"2019","unstructured":"Trevisan K, Cristina-Pereira R, Silva-Amaral D, Aversi-Ferreira TA (2019) Theories of aging and the prevalence of Alzheimer\u2019s disease. BioMed Res Int 2019:1\u20139","journal-title":"BioMed Res Int"},{"key":"1099_CR85","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.neurol.2019.03.004","volume":"176","author":"I Vatanabe","year":"2020","unstructured":"Vatanabe I, Manzine P, Cominetti M (2020) Historic concepts of dementia and Alzheimer\u2019s disease: from ancient times to the present. Rev Neurol (paris) 176:140\u2013147","journal-title":"Rev Neurol (paris)"},{"key":"1099_CR86","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2174\/156720511795256053","volume":"8","author":"B Vellas","year":"2011","unstructured":"Vellas B, Sol O, Snyder JP, Ousset P-J, Haddad R, Maurin M, Lemari\u00e9 J-C, D\u00e9sir\u00e9 L, Pando PM (2011) EHT0202 in Alzheimer\u2019s disease: a 3\u00a0month, randomized, placebo-controlled, double-blind study. Curr Alzheimer Res 8:203\u2013212","journal-title":"Curr Alzheimer Res"},{"key":"1099_CR87","doi-asserted-by":"publisher","first-page":"530","DOI":"10.37358\/RC.17.3.5495","volume":"68","author":"CS Vlad","year":"2017","unstructured":"Vlad CS, Dumitrascu V, Vlad DC, Cimporescu A, Popescu R, Dehelean L, Marincu I, Citu IM, POENARU D, (2017) Fast and simple method for simultaneous detection and quantification of diazepam and desmethyldiazepam in plasma samples in psychiatric patients by GC-MS-FID. Rev Chim (bucharest) 68:530\u2013533","journal-title":"Rev Chim (bucharest)"},{"key":"1099_CR88","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s00415-020-09937-7","volume":"267","author":"J V\u00f6glein","year":"2020","unstructured":"V\u00f6glein J, Ricard I, Noachtar S, Kukull WA, Dieterich M, Levin J, Danek A (2020) Seizures in Alzheimer\u2019s disease are highly recurrent and associated with a poor disease course. J Neurol 267:2941\u20132948","journal-title":"J Neurol"},{"key":"1099_CR89","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1111\/j.1460-9568.2004.03688.x","volume":"20","author":"H Wan","year":"2004","unstructured":"Wan H, Warburton E, Zhu X, Koder T, Park Y, Aggleton JP, Cho K, Bashir Z, Brown M (2004) Benzodiazepine impairment of perirhinal cortical plasticity and recognition memory. Eur J Neurosci 20:2214\u20132224","journal-title":"Eur J Neurosci"},{"key":"1099_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2018.10.027","volume":"75","author":"RA Whittington","year":"2019","unstructured":"Whittington RA, Vir\u00e1g L, Gratuze M, Lewkowitz-Shpuntoff H, Cheheltanan M, Petry F, Poitras I, Morin F, Planel E (2019) Administration of the benzodiazepine midazolam increases tau phosphorylation in the mouse brain. Neurobiol Aging 75:11\u201324","journal-title":"Neurobiol Aging"},{"key":"1099_CR91","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4140\/TCP.n.2013.538","volume":"28","author":"J Wick","year":"2013","unstructured":"Wick J (2013) The history of benzodiazepines. The Consul Pharm 28:538\u2013548","journal-title":"The Consul Pharm"},{"key":"1099_CR92","doi-asserted-by":"publisher","first-page":"208","DOI":"10.9740\/mhc.2018.09.208","volume":"8","author":"AM Williams","year":"2018","unstructured":"Williams AM (2018) Coadministration of intramuscular olanzapine and benzodiazepines in agitated patients with mental illness. Mental Health Clin 8:208\u2013213","journal-title":"Mental Health Clin"},{"key":"1099_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-0358-9","volume":"15","author":"T Williams","year":"2020","unstructured":"Williams T, Borchelt DR, Chakrabarty P (2020) Therapeutic approaches targeting apolipoprotein E function in Alzheimer\u2019s disease. Mol Neurodegener 15:1\u201319","journal-title":"Mol Neurodegener"},{"key":"1099_CR94","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41588-020-00773-z","volume":"53","author":"AP Wingo","year":"2021","unstructured":"Wingo AP, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM, Dammer EB, Robins C, Beach TG, Reiman EM (2021) Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer\u2019s disease pathogenesis. Nat Genet 53:143\u2013146","journal-title":"Nat Genet"},{"key":"1099_CR95","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1111\/jgs.17101","volume":"69","author":"Y Xu","year":"2021","unstructured":"Xu Y, Lavrencic L, Radford K, Booth A, Yoshimura S, Anstey KJ, Anderson CS, Peters R (2021) Systematic review of coexistent epileptic seizures and Alzheimer\u2019s disease: Incidence and prevalence. J Am Geriatr Soc 69:2011\u20132020","journal-title":"J Am Geriatr Soc"},{"key":"1099_CR96","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu C-C, Bu G (2019) Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol 15:501\u2013518","journal-title":"Nat Rev Neurol"},{"key":"1099_CR97","doi-asserted-by":"publisher","first-page":"e3029","DOI":"10.1371\/journal.pone.0003029","volume":"3","author":"Y Yoshiike","year":"2008","unstructured":"Yoshiike Y, Kimura T, Yamashita S, Furudate H, Mizoroki T, Murayama M, Takashima A (2008) GABAA receptor-mediated acceleration of aging-associated memory decline in APP\/PS1 mice and its pharmacological treatment by picrotoxin. PLoS ONE 3:e3029","journal-title":"PLoS ONE"},{"key":"1099_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2047-9158-3-8","volume":"3","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Shao H, Dong Y, Swain CA, Yu B, Xia W, Xie Z (2014) Chronic treatment with anesthetic propofol attenuates \u03b2-amyloid protein levels in brain tissues of aged mice. Transl Neurodegener 3:1\u20137","journal-title":"Transl Neurodegener"},{"key":"1099_CR99","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbr.2011.12.013","volume":"228","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Wang Z, Dai J, Chen L, Huang Y, Zhan Z (2012) Beneficial effects of benzodiazepine diazepam on chronic stress-induced impairment of hippocampal structural plasticity and depression-like behavior in mice. Behav Brain Res 228:339\u2013350","journal-title":"Behav Brain Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-01099-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-01099-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T05:24:52Z","timestamp":1677216292000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-01099-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1099"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-01099-4","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]},"assertion":[{"value":"2 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent statement"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}}]}}